PostEra vs Synthace

PostEra logo

PostEra

Medicinal Chemistry powered by Machine Learning

43 employees · est. 2019 · Boston, United States

VS
Synthace logo

Synthace

Helping scientists solve the world's most pressing problems with faster, more powerful experiments

36 employees · est. 2011 · London, United Kingdom

Synthace is the older company (2019 vs 2011).

Side-by-Side Comparison

PostEra Synthace
Founded
2019 2011 older
Headquarters
Boston, United States London, United Kingdom
Employees
43 36
Industry
AI, Biotechnology, Health and Wellness Automation, Biotechnology, Life Sciences
Funding Stage
Series A Series C
Total Funding
$24.13M $75.00M
Funding Rounds
4 13
Services
AI Platform for Drug Discovery, Medicinal Chemistry, Pharmaceutical Collaborations, Drug Development Automated multivariate experiments, Assay development, Media optimization, Miniaturized purification, Software for high dimensional data analysis, On-site support and training
Target Customers
Pharmaceutical Companies, Biotechnology Firms, Medical Research Institutions Pharmaceutical companies, Biotechnology firms, Research and development teams, Academia, Biotechnology startups
Taxonomy
AI-first BiotechMedicinal ChemistryMachine Learning In Drug DiscoveryWomen’s HealthFertility TreatmentClinical Candidates +9 Digital Experiment PlatformLife Science R&DLab AutomationBiological InsightMultifactorial ExperimentsData Structuring +8
Website
postera.ai synthace.com
PostEra logo

About PostEra

PostEra, founded in 2019, is a pioneering startup at the intersection of AI and biotechnology, headquartered in the United States. The company leverages its proprietary AI platform, Proton, to revolutionize medicinal chemistry, aiming to accelerate the discovery and development of new medicines. Em...

Synthace logo

About Synthace

Synthace, established in 2011 and headquartered in the United Kingdom, is making significant strides in the biotech industry with its advanced software solutions. Positioned within the Automation, Biotechnology, Life Sciences, and Pharmaceutical sectors, Synthace offers an innovative, end-to-end sof...

Also comparing in this category

Comparing more than these two?

Get PostEra, Synthace and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does PostEra compare?

A PDF of PostEra and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Frequently Asked Questions

PostEra was founded in 2019, based in Boston, United States, with 43 employees. PostEra, founded in 2019, is a pioneering startup at the intersection of AI and biotechnology, headquartered in the United States. The company leverages its proprietary AI platform, Proton, to revolut. Synthace was founded in 2011, based in London, United Kingdom, with 36 employees. Synthace, established in 2011 and headquartered in the United Kingdom, is making significant strides in the biotech industry with its advanced software solutions. Positioned within the Automation, Bio.
PostEra has raised $24.13M and Synthace $75.00M. Latest stage: PostEra Series A, Synthace Series C.
Both work in Biotechnology and Pharmaceutical.

Compare PostEra with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at PostEra on 14 Sep 2026, and Synthace on 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes